The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics

Advances in Experimental Medicine and Biology

Volumn 666, Issue , 2009, Pages 132-156

  Lucas, Alexandra ^a   Liu, Liying ^b   Dai, Erbin ^b   Bot, Ilze ^b   Viswanathan, Kasinath ^b   Munuswamy Ramunujam, Ganesh ^b   Davids, Jennifer A ^b   Bartee, Mee Y ^b   Richardson, Jakob ^b   Christov, Alexander ^b   Wang, Hao ^b   Macaulay, Colin ^b   Poznansky, Mark ^b   Zhong, Robert ^b   Miller, Leslie ^b   Biessen, Erik ^b   Richardson, Mary ^b   Sullivan, Collin ^b   Moyer, Richard ^b   Hatton, Mark ^b   Lomas, David A ^b   McFadden, Grant ^b   more..

^a UNIVERSITY OF FLORIDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; CASPASE 3; CYCLOSPORIN A; CYTOKINE RESPONSE MODIFIER A; GRANZYME B; LAMININ; MASPIN; NEUROSERPIN; PROTEASE NEXIN; SERINE PROTEASE INHIBITOR 2; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR CRMA; SERINE PROTEINASE INHIBITOR SERP 1; SERINE PROTEINASE INHIBITOR SERP 2; SERINE PROTEINASE INHIBITOR SPI 3; SERINE PROTEINASE INHIBITOR SPI2 SERPIN B13R; SERPIN A5; SERPIN B2; SERPIN E1; SERPIN F2; SRPN 10; STREPTOKINASE; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; VIRUS PROTEIN;

ABSENCE OF SIDE EFFECTS; ACUTE CORONARY SYNDROME; ACUTE GRAFT REJECTION; ANGIOGENESIS; ANGIOPLASTY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTHRITIS; ARTICLE; BLOOD VESSEL INJURY; BRAIN ISCHEMIA; CELL GROWTH; CHORIOALLANTOIS; CHRONIC GRAFT REJECTION; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CYTOTOXIC T LYMPHOCYTE; DRUG ACTIVITY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; HEART TRANSPLANTATION; HUMAN; IMMUNOTHERAPY; INNATE IMMUNITY; LOW DRUG DOSE; MAMMAL; MONOTHERAPY; NATURAL KILLER CELL; NERVE CELL PLASTICITY; NERVE FIBER; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PILOT STUDY; PLAGUE; PRIORITY JOURNAL; RABBIT; SERP 1 GENE; SINGLE DRUG DOSE; STENOSIS; STROKE; THERMODYNAMICS; THROMBOCYTE ACTIVATION; THROMBOSIS; UNSTABLE ANGINA PECTORIS; VASCULAR STENOSIS; VISUAL CORTEX; ANIMAL; IMMUNOPATHOLOGY; REVIEW; VIRUS INFECTION;

ANGINA; DINOSAURIA; MAMMALIA; MEROSTOMATA; METAZOA; PROTOZOA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; IMMUNE SYSTEM DISEASES; SERINE PROTEINASE INHIBITORS; SERPINS; VIRAL PROTEINS; VIRUS DISEASES;

EID: 75649117820     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1601-3_11     Document Type: Article

References (108)

1. Sulek K. Prize in 1908 awarded to P Erlich and E Metchnikoff for their work in immunology. Wiad Leuk 1967; 20:1117-1118.
2. Opitz B, Hippenstiel S, Eitel J et al. Extra and intracellular innate immune recognition in endothelial cells. Thromb Haemost 2007; 98:319-326. (Pubitemid 47250234)
3. Mariathasan S, Monack DM. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nature Rev Immunol 2007; 7:31-40. (Pubitemid 46020825)
4. Brown KL, Cosseau C, Gardy JL et al. Complexities oftargeting innate immunity to treat infection. Trends Immunol 2007; 28:260-266. (Pubitemid 46824085)
5. Lin WW; Karin M. A cytokine mediated link between innate immunity, inflammation and cancer. J Clin Invest 2007; 117:1175-1183. (Pubitemid 46718402)
6. Ware C. Network communications: Lyrnphotoxins, light and TNF. Annu Rev Immunol 2005; 23:787-819. (Pubitemid 40563185)
7. Roy CR, Mocarski ES. Nature Imm 2007; 8:1179-1187.
8. Parker Le, Prince LR, Sabroe I. Translational minireview series on toll-like receptors: Networks regulated by toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol 2007; 147:199-207. (Pubitemid 46095996)
9. Methe H, Weis M. Atherogenesis and inflammation-was Virchow right? Nephrol Dial Transplant 2007; 22:1823-1827.
10. Schneider DF, Glenn CH, Faunce DE. Innate lymphocyte subsets and their immunoregulatory roles in burn injury and sepsis. J Burn Care and Research 2007; 28:365-379. (Pubitemid 46733242)
11. Opal SM, Esmon CT. Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the parhogenesis of sepsis. Crit Care 2003; 7:23-38. (Pubitemid 36204267)
12. Jancaiuskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochem Biophys Acta 2001; 1535:221-235.
13. Lomas DA, Belorgey D, Mallya M et al. Molecular mousetraps and the serpinoparhies. Biochem Soc Transaction 2005; 33:321-330
14. Carrell RW; Travis J. α l-Anrirrypsin and rhe serpins: Variation and counrervariation, Trends Biochem Sci 1985; 10:20-24. (Pubitemid 15158724)
15. Irving JA, Pike RN, Lesk AM et al. Phylogeny of the serpin superfamily: Implications of patterns of amino acid conservation for structure and function. Genome Res 2000; 10:1845-1864. (Pubitemid 32049132)
16. Iwanaga S, Kawabata S. Evolution and phylogeny of defense molecules associated with innate immunity in horseshoe crab. Front Biosci 1998; 3:D973-984.
17. Law RHP, Zhang Q, McGowan S et al. An overview of the serpin superfamily. Genome Biol 2006; 7:216.2-216.11
18. Silverman GA, Bird PI, Carrell RW et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. J Biol Chem 2001; 276:33293-33296.
19. Marszal E, Shrake A. Serpin crystal structure and serpin polymer structure. Arch Biochem Biophys 2006; 453:123-129.
20. Huntington JA, Read RJ, Carrell RW Nature 2000; 407:923-926.
21. Patsron PA, Church FC, Olson ST. Serpin-Iigand interactions. Methods 2004; 32:93-109.
22. Ye S, Cech AL, Belmares R et al. The structure of a michaelis serpin-protease complex. Nat Struct Biol 2001; 8:979-983 (Pubitemid 33032368)
23. Lawrence DA, Olson ST, Muhammad S et al. Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate ofserpin reactive center loop insertion into β-sheet A. J Biol Chem 2000; 275:5839-5844. (Pubitemid 30115230)
24. Whisscock JC, Bonornley SP. Molecular gymnastics: serpin structure, folding and misfolding. Curr Opin Srrucr Biol 2006; 16:761-768
25. Li W;Johnson DJ, Esmon CT et al. Structure of the antithrombin-rhrombin- heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 2004; 11:857-862. (Pubitemid 39128802)
26. Johnson DJ, Li W; Adams TE et al. Antithrombin-Sl95A factor xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J 2006; 25:2029-2037.
27. Dai E, Viswanathan K. Sun YM et al. Identification of myxomaviralserpin reactive site loop sequences thar regulate innate immune responses. J Biol Chem 2006; 281:8041-8050 (Pubitemid 43847422)
28. Dai E, Guan H. Liu L et al. Serp-I , a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury. J Biol Chem 2003 ; 278:18563-18572 (Pubitemid 36799483)
29. Ewa Marszal, Andrew Shrake. Serpin crystal structure and serpin polymer structure. Arch Biochern Biophys 2006 ; 453 :123-129.
30. Blasi F. Proteolysis, cell adhesion, chemotaxis and invasiveness arc regulated by the uPA-uPAR-PAI-1system. Thromb Haernost 1999; 82:298.
31. Carmeliec P, Collen D. Molecular analysis of blood vessel formation and disease. Am J Physiol Heart Circ Physiol 1997; 273:H2091-H2104
32. YepesM, Lawrence DA. Neuroserpin: a selective inhibitor oftissue-type plasminogen activator in the central nervous system. 'Ihromb Haernost 2004; 91:457-464. (Pubitemid 38396867)
33. YepesM, Sandkvist M. Wong MK et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoprosis, Blood 2000; 96:569-576. (Pubitemid 30463377)
34. Carmeliet P, Moons L, Lijnen R et al. Inhib itory role ofplasminogen activator inhibiror- I in arterial wound healing and neointima formation . Circulation 1997; 96:3180-3191 (Pubitemid 27500124)
35. Falkenberg M, Tom C, DeYoung MB et al. Increased expression of urokinase during atherosclerotic lesion development causes arterial consrriction and lumen loss and accelerates lesion growth. PNAS 2002; 99:10665-10670.
36. Ploplis VA, Castellino FJ. Attenuation of neointima formation following arteri al injury in PAI-1 deficient mice. Ann NY Acad Sci 2001; 936:466-468 (Pubitemid 32613931)
37. Strauss BH, Lau HK, Bowman KA et al. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coron ary restenosis, Circulation 1999; 100:1616-1622 (Pubitemid 29477270)
38. Vaughan DR. PAI-1 and atherothrombosis. J Thromb and Haemostasis 2005; 3:1879-1883
39. Munuswamy Ramunujam G, Lucas A. Mammalian serine prolease inhibitor (serpin), neuroserpin, targets thrombolytic proteases 10 reduce inflarnmarion, atherogenesis and T helper lympho cyre activation. Poster, American Heart Association. Orlando, FL 2007
40. Bormer CD, Cidlowski JA. Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol 2002; 42:259-281. (Pubitemid 34162545)
41. Trapani JA. Granzymes : a family of lymphocyre granule serine proleases. Genome Biol 2001 ; 2:30141-30147
42. Roemisch J. Gray E, Hoffmann IN et al. Antithrombin: a new look at the actions of a serine prolease inh ibitor, Blood Coagul Fibrinolysis 2002; 13:657-670. (Pubitemid 36026822)
43. Mariathasan S, Monack DM. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation . Nature Rev Immunol 2007; 7:31-40 (Pubitemid 46020825)
44. Taniguchi S, Sagara J. Regulatory molecules involved in inflammasome formation with special reference to a key mediator protein, ASC. Semin Immunopathol 2007; 29:231-238. (Pubitemid 47416220)
45. Zhou Q,Snipas S, Orth K et al. Target proleases of the viral serpin CrmA: Analysis of five caspases. J Biol Chem 1997; 272:7797-7800. (Pubitemid 27137336)
46. Moffitr KL. Marlin SL, Walker B.The emerging role ofserine pro teases in apoptosis. Biochem Soc Transactions 2007; 35:559-560. (Pubitemid 46975075)
47. Bird CH, Sutton YR. Sun J et al. Selective regulation of apoptos is: the cytotoxic lymphocyte serpin proteinase inhibitor 9 proteclS against granzyme B-mediared apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol 1998; 18:6387-6398. (Pubitemid 28500528)
48. Medcalf RL, Stasinopoulos SJ. The undecided serpin: the ins and outs of plasminogen activator inhibitor Type 2. FEBS J 2005; 272:4858-4867. (Pubitemid 41415110)
49. Cinelli P. Maadani R. Tsuzuki N et al. Neuroserpin, a neuroprorecrive factor in focal ischemic stroke. Mol Cell Neurosci 2001; 18:443-457. (Pubitemid 34008386)
50. Khalkhaliellis Z. Maspin: The new frontier. Clin Cancer Res 2006; 12:7279-7283.
51. Kai OK, Kishi T, Kamachi T et al. Serine proteinase inhibitor 3 and murinoglobulin I arc potent inhibitors of neuroserpin in adult mouse brain. J Biol Chem 2001; 276:14562-14571.
52. Sun J. Ooms L, Bird CH et al. A new family of 10 murine ovalbumin serpins includes two homologs of proreinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9). J Biol Chem 1997; 272:15434-15441. (Pubitemid 27255569)
53. Charron Y,Madani R, N'efS et al. Expression ofserpinb6 serpins in germ and somatic cellsof mouse gonads. Mol Repro Develop 2006: 73:9-19. (Pubitemid 41759947)
54. Suzuki K, Hayashi T. Protein C and its inhibitor in malignancy. Sem Thrornb Haem 2007; 33:667-672. (Pubitemid 350157010)
55. Miyamoto Y. Akaike T, Alam MS et al. Novel functions of human alpha(l)-protease inhibitor after S-nitro sylation: inhibition of cysteine protea se and antibacterial acriviry, Biochern Biophys Res Commun 2000; 267:918-923. (Pubitemid 30099423)
56. Fermer F. Woodroffe GM. The pathogenesis of infectious myxomatosis: the mechanism of infection and the immunological response in the European rabbit (oryctolagus cuniculus). BrJ Exp Pathol 1953; 34:400-411.
57. Upton C. Macen JL, Wishart DS et al Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology 1990; 179:618-631.
58. Macen JL. Upton C, Nation N et al. SERPI, a serine proteinase inhibitor encoded by myxoma virus. is a secreted glycoprotein that interferes with inflammation. Virology 1993; 195:348-363.
59. Xing LI, Schneider H. Peters A et al. Heparin binding alters viral serine protease inhibitor (serp-I) activity. Open BiochemJ 2008; 2:6-15.
60. Nash P. Whircy A. Handwerker J et al. Inhibitory specificity of the anti-inflammarory myxoma virus serpin, serp-l.J Biol Chcm 1998; 273:20982-20991. (Pubitemid 28385381)
61. Lucas A. Li X. Schneider H et al. Heparin alters viral serpin, serp-I, anti-thrombolytic activiry to anti-thrombotic acrivity. Open BiochemJ 2007; 2:6-15
62. Turner PC. Moyer RW The cowpox virus fusion regulator proteins SPI3 and hemagglutinin interact in infected and uninfected cells. Virology 2006; 347:88-99.
63. Turner PC. Baquero MT. Yuan S et al. The cowpox virus serpin spi-3 complexes with and inhibits urokinase-eype and tissue-type plasminogen activators and plasmin. Virology 2000; 272:267-280. (Pubitemid 30480188)
64. Lucas A. Liu LY, Macen J et al. Virus-encoded serine proteinase inhibitor serp-I inhibits atherosclerotic plaque development after balloon angioplasty. Circulation 1996; 94:2890-2900. (Pubitemid 26411757)
65. HarconMWRoss B. Southward SM et al. Metabolism and distribution of the virus-encoded serine proteinase inhibitor serp-I in healthy rabbits. Metabolism 2000; 49: 1449-1452.
66. Lucas A. Dai E. Liu L et al. Transplant vasculopathy: Viral anti-inflammatory serpin regulation of atherogenesis. J Heart Lung Transplant 2000; 19: 1029-1038.
67. Bot I. von der thusen JH. Donners MMPC et al. Serine protease inhibitor serp-I strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/- mice. Circulation 2003; 93:464-471. (Pubitemid 37100012)
68. Miller LW; Dai E. Nash P et al. Nation. Robert Zhong, Grant Mcfadden and Alexandra Lucas Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpin. Circulation 2000; 101:1598-1605. (Pubitemid 30180898)
69. Bedard ELR. JiangJ. Arp J et al. Prevention of chronic renal allograft rejection by serp-I protein. Transplantation 2006; 81:908-914.
70. Hausen B. Boeke K. Berry GJ et al. Viral serine proteinase inhibitor (serp-I) effectively decreases the incidence of graft vasculoparhy in heterotopic heart allografts. Transplantation 200 I; 72:364-368 (Pubitemid 32769618)
71. Jiang J. Arp J. Kubelik D et al. Induction of indefinite cardiac allograft survival correlates with toll-like receptor 2 and 4 downregulation after serine protease inhibitor-I (serp-I) treatment. Transplantation 2007; 84:1158-1167. (Pubitemid 350125359)
72. Maksymowych wp. Nation N, Nash P et al. Amelioration of antigen induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor.J RheumatoI1996; 23:878-882. (Pubitemid 26157765)
73. Brahn E, Do L. Lee S et al. Suppression ofcollagen-induced arthritis with a serin proteinase inhibitor cloned from a myxoma viral sequence. Arthritis and rheumatism 2000 annual scientific meeting, Philadelphia, PA. Abstract Supplement. American College of Rheumatology 2000; abstract no. 1000:43(9).
74. Richardson M, Liu L. Dunphy L et al. Viral serpin, serp-I, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model. Cardio Path 2007; 16:191-202. (Pubitemid 47048751)
75. Visinathan K, Liu L. Vaziri S et al. Myxoma viral serpin, serp-I, a unique interceptor of coagulation and innate immune pathways. Thromb Haemost 2006; 95:499-510.
76. MacNeill AL. Turner PC. Moyer RW Mutation of the myxoma virus serp-2 P1-site to prevent proteinase inhibition causes apoptosis in cultured RK-13 cells and attenuates disease in rabbits, but mutation to alter specificity causes apoptosis without reducing virulence. Virology 2006; 356: 12-22. (Pubitemid 44750025)
77. Turner PC, Sancho MC. Thoennes SR et al. Myxoma virus serp-Z is a weak inhibitor of granzyme B and inrerleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virusinfected cells. J Virol 1999; 73:6394-6404. (Pubitemid 29327817)
78. Messud Petit F. GelfiJ, Delverdier M et al. Serp-2, an inhibitor of the inrerleukin-Ibeta-converting enzyme, is critical in the pathophysiology of myxoma virus.J Viro11998; 72:7830-7839. (Pubitemid 28421773)
79. Nathaniel R. MacNeill AL. Wang YX et al. Cowpox virus CrrrtA, myxoma virus serp-2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections. J Gen Virol 2004; 85:1267-1278. (Pubitemid 38659791)
80. Lurcge BG, Moyer RW Suppressors of a host range mutation in the rabbitpox virus serpin spi-I map to proteins essential for DNA replication.J Virol 2005; 79:9168-9179.
81. Viswanathan K, Bot I. Liu L et al. Viral cross-class serpin inhibits apoprosis, inflammation and atherosclerosis. In: Modulation of Atherothrombotic Factors: Novel Strategies for Plaque Stabilization. Print Partners Ipstarnp Enschede, The Netherlands 2005; pg 61-76.
82. Viswanathan K, Bot I, LiuL et al.Viralcross-class serpininhibits apoptosis, in Hanunation and atherosclerosis. In modulation of atherothrombotic factors: Novelstrategiesfor plaque stabilization. Print Partners Ipstarnp Enschede The Netherlands 2005:61-76.
83. Abraharn EG,Jacobs Lorena M. Mosquito midgut barriers to malaria parasite development. Insect Biochem Mol Biol 2004; 34:667-671.
84. Caljon G, Van Den AbbeeleJ, Stijlemans B et al. Tsetse fly saliva accelerates the onset of trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response. Infect Immun 2006; 74:6324-6330. (Pubitemid 44657414)
85. Danielli A, Kafatos FC, Loukeris TG. Cloning and characterization of four anopheles gambiae serpin isoforms, differentially induced in the midgut by plasmodium berghei invasion. J Biol Chem 2003; 278:4184-4193. (Pubitemid 36801156)
86. Danielli A, Barillas Mury C, Kumar S et al. Overexpression and altered nucleocytoplasmic distribution of anopheles ovalbumin-like SRPNI0 serpins in plasmodium-infected midgut cells. Cell Microbiol 2005; 7:181-190. (Pubitemid 40259734)
87. Michel K, Budd A, Pinto S et al. Anopheles garnbiae SRPN2 facilitates midgut invasion by the malaria parasite plasmodium berghei.EMBO Rep 2005; 6:891-897. (Pubitemid 43108682)
88. Michel K, Suwanchaichinda E. Morlais I et al. Increasedmelanizing activityin anopheles garnbiae does not affectdevelopmentof plasmodiumfalciparum. Proc Natl Acad Sci USA 2006; 103:16858-16863. (Pubitemid 44737343)
89. AbraharnEG, Pinto SB, Ghosh A et al.An immune-responsive serpin, SRPN6, mediatesmosquito defense against malaria parasites. Proc Natl Acad Sci USA 2005; 102:16327-16332. (Pubitemid 41688913)
90. De Gregorio E, Spellman PT, Rubin GM et al. Genome-wide analysis of the drosophila immune response by using oligonucleotide microarrays. Proc Natl Acad Sci USA 2001; 98:12590-12595. (Pubitemid 33019990)
91. Perlmutter DH, Joslin G, Nelson P et al. Endocytosis and degradationof alpha l-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor.J Biol Chem 1990; 265:16713-16716.
92. Pleass RJ, KuselJR, WoofJM. Cleavage of human 19Emediated by schistosoma mansoni.Int Arch Allergy Immunol 2000; 121:194-204. (Pubitemid 30157705)
93. Zang X, AtmadjaAK, Gray P et al. The serpin secretedby brugia malayi microfilariae, Bm-SPN-2, elicits strong, but short-lived, immune responses in mice and humans.J Immunol 2000; 165:5161-5169.
94. Manoury B, GregoryWE Maizels RMet al. Bm-CPI-2, a cystatinhomolog secretedby the filarial parasite brugia malayi, inhibits class Il MHC-restricted antigen processing. Curr Biol 2001; 11:447-451. (Pubitemid 32241523)
95. Newlands GF, Skuce PJ, Knox DP et al. Cloning and expression of cystatin, a potent cysteine protease inhibitor from the gut of haemonchus contortus, Parasitology 2001; 122:371-378. (Pubitemid 32234880)
96. Peanasky RJ, Bentz Y, Paulson B et al. The isoinhibitors of chymotrypsin/elastase from ascaris lumbricoides: isolation by affinity chromatography and associarion with the enzymes. Arch Biochem Biophys 1984; 232:127-134.
97. Schonemeyer A, Lucius R, SonnenburgB et al. Modulation of human T-cell responses and macrophage functions by onchocystatin, a secreted protein of the filarial nematode onchocerca volvulus. J Immunol 2001; 167(6):3207-3215. (Pubitemid 32852560)
98. PfaffAW, SchulzKeyH, Soboslay PT et al.Litomosoides sigmodontis cystatinacts as an immunomodulator during experimental filariasis. Inr J Parasitol2002; 32:171-178. (Pubitemid 34112623)
99. Dainichi T, Maekawa Y, Ishii K et al. Nippocystatin, a cysteine protease inhibitor from nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response. Infect Immun 2001; 69:7380-7386. (Pubitemid 33086562)
100. Rhoads ML, Fetterer RH, Hill DE et al. Trichuris suis: a secretory chymotrypsin/elastase inhibitor with potential as an immunomodulator. Exp Parasitol2000; 95:36-44. (Pubitemid 30415951)
101. Zang X, Maizels RM. Serine proteinase inhibitors from nematodes and the arms race between host and pathogen. Trends BiochemSci 2001; 26:191-197. (Pubitemid 32197580)
102. Limo MK, Voigt WP, Tumbo Oeri AG et al. Purification and characterization of an anticoagulant from the salivary glands of the ixodid tick rhipicephalus appendiculatus. Exp Parasitol 1991; 72:418-429.
103. Joubert AM, CrausejC, GasparAR et al. Isolation and characterization of an anticoagulantpresent in the salivary glands of the bone-legged tick, hyalommatruncarum. Exp Appl Acaro11995; 19:79-92.
104. MulengaA, SugimotoC, IngramG et al. Characterizationof two cDNAs encodingserineproteinasesfrom the hard tick haemaphysalis longicornis. Insect Biochem Mol Biol 2001; 31:817-825. (Pubitemid 32587304)
105. Prevot PP, Adam B, BoudjeltiaKZ et al. Anti-hemostatic effects of a serpin from the salivaof the tick ixodesricinus.J Biol Chem 2006; 281(36):26361-26369. (Pubitemid 44401844)
106. Leboulle G, Crippa M, Decrem Y et al. Characterization of a novel salivary immunosuppressive protein from ixodesricinus ticks.J BiolChem 2002; 277:10083-10089. (Pubitemid 34968118)
107. Borges M, Da Silva AC, Sereno D et al. Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of trypanosoma cruzi Tc52 virulence factor. Immunology 2003; 109:147-155. (Pubitemid 36577985)
108. RichardsonJ, Viswanathan K, Lucas A. Serpins, the vasculature and viral therapeutics. Front Biosci 2006; 11:1042-56.